Research and Markets: Orphan Drugs Market 2015-2019

DUBLIN–(BUSINESS WIRE)–Research and Markets (
has announced the addition of the “Orphan
Drugs Market 2015-2019”
report to their offering.

The report forecasts the global orphan drugs market to grow at a CAGR of
10.05% over the period 2014-2019.

The report covers the current scenario and the growth prospects of the
global orphan drugs market for the period of 2015-2019. To calculate the
market size, the report considers revenue generated from the sales
orphan drugs.

According to WHO, orphan or rare diseases are the pathological
conditions that affect 0.65-1 out of 10,000 population worldwide. There
are around 6,000 orphan diseases, of which 80% are genetic. Orphan drugs
are developed by the pharmaceutical industry to serve the public health
need. These are designated as “Orphan Designations” by the regulatory
agencies to accelerate the approval process.

The report has been prepared based on an in-depth market analysis with
inputs from industry experts. The report covers the Americas, APAC, and
Europe; it also covers the landscape of the global orphan drugs market
and its growth prospects in the coming years. The report includes a
discussion of the key vendors operating in this market.

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Overview

PART 06: Pipeline snapshot

PART 07: Market landscape

PART 08: Market segmentation by product

PART 09: Geographical segmentation

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

PART 16: Key vendor analysis

Companies Mentioned:

  • Bristol-Mayer Squibb
  • Celgene
  • F. Hoffmann La Roche
  • Novartis
  • Pfizer
  • AbbVie
  • Actelion Pharmaceuticals
  • Alexion Pharmaceuticals
  • Alnylam Pharmaceuticals
  • Amgen
  • AstraZeneca
  • Baxter International
  • Biogen Idec
  • Celldex Therapeutics
  • GlaxoSmithKline
  • Eisai
  • Eli Lilly
  • Intercept Pharmaceuticals
  • Johnson & Johnson
  • Merck
  • Northwest Biotherapeutics
  • NewLink Genetics
  • Novo Nordisk
  • Onyx Pharmaceuticals
  • Sanofi
  • Shire
  • Takeda
  • Synageva BioPharma
  • Vertex Pharmaceuticals
  • XOMA.

For more information visit


Research and Markets
Laura Wood, Senior Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals